141 related articles for article (PubMed ID: 21123367)
1. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
Liu JL; Mao Z; Gallick GE; Yung WK
Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367
[TBL] [Abstract][Full Text] [Related]
2. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma.
Lu KH; Wu W; Dave B; Slomovitz BM; Burke TW; Munsell MF; Broaddus RR; Walker CL
Clin Cancer Res; 2008 May; 14(9):2543-50. PubMed ID: 18451215
[TBL] [Abstract][Full Text] [Related]
3. AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2.
Fogarty S; Ross FA; Vara Ciruelos D; Gray A; Gowans GJ; Hardie DG
Mol Cancer Res; 2016 Aug; 14(8):683-95. PubMed ID: 27141100
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells.
Hawley SA; Ross FA; Gowans GJ; Tibarewal P; Leslie NR; Hardie DG
Biochem J; 2014 Apr; 459(2):275-87. PubMed ID: 24467442
[TBL] [Abstract][Full Text] [Related]
5. Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells.
Akasaka Y; Hasei S; Ohata Y; Kanna M; Nakatsu Y; Sakoda H; Fujishiro M; Kushiyama A; Ono H; Matsubara A; Hinata N; Asano T; Yamamotoya T
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958994
[No Abstract] [Full Text] [Related]
6. AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell.
Han G; Gong H; Wang Y; Guo S; Liu K
Cancer Biol Ther; 2015; 16(1):77-87. PubMed ID: 25456211
[TBL] [Abstract][Full Text] [Related]
7. Porcine circovirus type 2 induces autophagy via the AMPK/ERK/TSC2/mTOR signaling pathway in PK-15 cells.
Zhu B; Zhou Y; Xu F; Shuai J; Li X; Fang W
J Virol; 2012 Nov; 86(22):12003-12. PubMed ID: 22915817
[TBL] [Abstract][Full Text] [Related]
8. Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
Vara-Ciruelos D; Dandapani M; Russell FM; Grzes KM; Atrih A; Foretz M; Viollet B; Lamont DJ; Cantrell DA; Hardie DG
Cell Rep; 2019 Apr; 27(3):690-698.e4. PubMed ID: 30995468
[TBL] [Abstract][Full Text] [Related]
9. Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle.
Hadad SM; Hardie DG; Appleyard V; Thompson AM
Clin Transl Oncol; 2014 Aug; 16(8):746-52. PubMed ID: 24338509
[TBL] [Abstract][Full Text] [Related]
10. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
[TBL] [Abstract][Full Text] [Related]
11. Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder.
Shorning BY; Griffiths D; Clarke AR
PLoS One; 2011 Jan; 6(1):e16209. PubMed ID: 21283818
[TBL] [Abstract][Full Text] [Related]
12. DENV-2 NS1 promotes AMPK-LKB1 interaction to activate AMPK/ERK/mTOR signaling pathway to induce autophagy.
Wu N; Ji J; Gou X; Hu P; Cheng Y; Liu Y; Wang Y; Zhang Q; Zuo L
Virol J; 2023 Oct; 20(1):231. PubMed ID: 37821951
[TBL] [Abstract][Full Text] [Related]
13. Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling.
Kou B; Shi Y; Zhou Z; Yun Y; Wu Q; Zhou J; Liu W
Int J Med Sci; 2024; 21(4):623-632. PubMed ID: 38464825
[TBL] [Abstract][Full Text] [Related]
14. Metformin activates AMPK and mTOR to Inhibit RANKL-stimulated osteoclast formation.
Kim YS; Park BS; Baek HS; Kang HM; Oh JM; Kim IR
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8795-8811. PubMed ID: 37782190
[TBL] [Abstract][Full Text] [Related]
15. STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Pencik J; Philippe C; Schlederer M; Atas E; Pecoraro M; Grund-Gröschke S; Li WJ; Tracz A; Heidegger I; Lagger S; Trachtová K; Oberhuber M; Heitzer E; Aksoy O; Neubauer HA; Wingelhofer B; Orlova A; Witzeneder N; Dillinger T; Redl E; Greiner G; D'Andrea D; Östman JR; Tangermann S; Hermanova I; Schäfer G; Sternberg F; Pohl EE; Sternberg C; Varady A; Horvath J; Stoiber D; Malcolm TI; Turner SD; Parkes EE; Hantusch B; Egger G; Rose-John S; Poli V; Jain S; Armstrong CWD; Hoermann G; Goffin V; Aberger F; Moriggl R; Carracedo A; McKinney C; Kennedy RD; Klocker H; Speicher MR; Tang DG; Moazzami AA; Heery DM; Hacker M; Kenner L
Mol Cancer; 2023 Aug; 22(1):133. PubMed ID: 37573301
[TBL] [Abstract][Full Text] [Related]
16. Genotoxic Damage Activates the AMPK-α1 Isoform in the Nucleus via Ca
Vara-Ciruelos D; Dandapani M; Gray A; Egbani EO; Evans AM; Hardie DG
Mol Cancer Res; 2018 Feb; 16(2):345-357. PubMed ID: 29133590
[TBL] [Abstract][Full Text] [Related]
17. Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy.
Huang CC; Chou CH; Yang YS; Ho HN; Shun CT; Wen WF; Chen SU; Chen MJ
Mol Hum Reprod; 2021 Jan; 27(1):. PubMed ID: 33543290
[TBL] [Abstract][Full Text] [Related]
18. TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling.
Lin CP; Traets JJH; Vredevoogd DW; Visser NL; Peeper DS
EMBO J; 2023 Mar; 42(5):e111614. PubMed ID: 36715448
[TBL] [Abstract][Full Text] [Related]
19. Development of a Genetically Engineered Mouse Model Recapitulating LKB1 and PTEN Deficiency in Gastric Cancer Pathogenesis.
Fang KT; Hung H; Lau NYS; Chi JH; Wu DC; Cheng KH
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136437
[TBL] [Abstract][Full Text] [Related]
20. SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage.
Lepore Signorile M; Sanese P; Di Nicola E; Fasano C; Forte G; De Marco K; Disciglio V; Latrofa M; Pantaleo A; Varchi G; Del Rio A; Grossi V; Simone C
Cells; 2023 Nov; 12(22):. PubMed ID: 37998381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
